Supplement, Dutaheal, Healing Pharma, Dutasteride 0.5 mg, Treatment for Benign Prostatic Hyperplasia, 100 tablets

Short Description: Dutaheal by Healing Pharma contains dutasteride 0.5 mg per tablet and is intended for men as part of a clinician-guided approach to Benign Prostatic Hyperplasia (BPH) management. Each bottle provides 100 tablets for convenient, consistent daily use.

Benefits: Designed to support symptom control associated with enlarged prostate, Dutaheal 0.5 mg helps address key factors linked to BPH when used as directed by a healthcare professional.

• Helps reduce prostate enlargement by inhibiting conversion of testosterone to DHT (dihydrotestosterone).
• Supports improved urinary flow and may help reduce urinary discomfort associated with BPH.
• May lower the risk of acute urinary retention, a potential complication of BPH.
• May reduce the need for BPH-related procedures in patients where clinically appropriate.

Instructions: Take 1 tablet (0.5 mg) once daily or exactly as prescribed by your healthcare provider. Swallow whole with water; do not crush or chew. It may be taken with or without food, but taking it at the same time each day is recommended for routine adherence.

Storage: Store in a cool, dry place, away from direct sunlight and moisture. Keep the bottle tightly closed and out of reach of children.

Precautions: For adult men only. Women, children, and adolescents must not use this product. Pregnant or potentially pregnant women should not handle broken or crushed tablets due to risk of absorption and potential harm to fetal development. Do not donate blood during treatment and for at least 6 months after stopping unless your clinician advises otherwise. Use caution and seek medical advice if you have liver disease or experience side effects such as decreased libido, erectile dysfunction, reduced semen volume, breast tenderness, or unusual fatigue. Always consult a healthcare professional for diagnosis, monitoring, and treatment duration.

Ingredients: Dutasteride 0.5 mg per tablet.